咨询热线:

020-3107 8154

GSK-J4

GSK J4 HCl是一种细胞渗透性的GSK J1前体药物,是第一个选择性H3K27组蛋白去甲基化酶JMJD3和UTX抑制剂,无细胞试验中IC50为60 nM,抑制JMJ家族的去甲基化酶活性。

  • 货号:
    TK0146
  • 规格:
    1mg
    2mg
    5mg
    10mg
  • 价格:
    0.00

产品参数

CAS No.1797983-09-5
生物活性GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 μM, respectively. GSK-J4 hydrochloride inhibits LPS-induced TNF-α production in human primary macrophages with an IC50 of 9 μM. GSK-J4 hydrochloride is a cell permeable prodrug of GSK-J1.
分子式C24H28ClN5O2
分子量453.96
运输条件Room temperature in continental US; may vary elsewhere.
储存条件Powder -20℃ 3 years
溶解性数据DMSO : 62.5 mg/mL (137.68 mM; Need ultrasonic)
体内研究GSK-J4 Hydrochloride (10 mg/kg; i.p.; thrice-weekly for 10 weeks) attenuates the development of kidney disease in diabetic mice. GSK-J4 Hydrochloride (0.5 mg/kg, i.p.) significantly reduces the severity and delays the onset of the disease of the mouse model of experimental autoimmune encephalomyelitis.
体外研究GSK-J4 Hydrochloride has cellular activity in Flag-JMJD3-transfected HeLa cells, in which GSK-J4 prevents the JMJD3-induced loss of nuclear H3K27me3 immunostaining. Administration of GSK-J4 increases total nuclear H3K27me3 levels in untransfected cells. GSK-J4 significantly reduces the expression of 16 of 34 LPS-driven cytokines, including tumour-necrosis factor-α (TNF-α). GSK-J4 Hydrochloride (5 μM; 48 hours) causes a more than 3-fold increase in mouse podocyte H3K27me3 content. H3K27me3 levels in cultured podocytes, GSK-J4 reduces Jagged-1 mRNA and Jagged-1 protein levels. Correspondingly, when exposed podocytes to the inducer of dedifferentiation TGF-β1, pretreatment with GSK-J4 preventes both the increase in intracellular N1-ICD levels and the increase in α-SMA and the decrease in podocin mRNA levels. GSK-J4 Hydrochloride (10, 25 nM) acts upon DCs promoting the differentiation of Treg cells, improving Treg stability and suppressive capacities, without affecting the differentiation of Th1 and Th17 cells. GSK-J4 Hydrochloride inhibits JMJD3 expression that is induced by TGF-β1. GSK-J4 Hydrochloride inhibits H3K4 demethylation at Xist, Nodal, and HoxC13 in female embryonic stem cells.
文献暂无相关参考文献
纯度及产品资料98%